Methylphenidate: Difference between revisions

Line 67:

*'''[[Effect::Ego inflation]]'''

*'''[[Effect::Emotion suppression]]''' - This is typically most intense at light and common doses, and is more commonly reported from medical usage rather than recreational.

*'''[[Effect::Derealisation]]''' - This effect is usually ~~reaported~~ at moderate/high doses.

*'''[[Effect::Derealisation]]''' - This effect is usually reported at moderate/high doses.

*'''[[Effect::Focus enhancement]]''' - This component is most effective at low to moderate dosages as anything higher will usually impair concentration.

*'''[[Effect::Wakefulness]]'''

Line 92:

*'''[[Effect::Thought deceleration]]'''

*'''[[Effect::Wakefulness]]'''

~~Some users report~~ methylphenidate to ~~have stronger after-effects than~~ [[~~amphetamine~~]] and [[~~caffeine~~]].

When methylphenidate compared to other stimulants such as [[Amphetamine]] and [[Caffeine]] it has worse after effects, which is like [[MDMA]].

}}

Line 141:

*'''[[MDMA]]''' - The neurotoxic effects of MDMA may be increased when combined with other stimulants.

Line 150:

Line 151:

*'''Austria''': Methylphenidate is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich).{{citation needed}}

*'''Canada''': Methylphenidate is listed in Schedule III of the Controlled Drugs and Substances Act (along with LSD, psychedelic mushrooms, and mescaline).<ref>{{cite web|url=http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-32.html#h-28|title=SCHEDULE III|publisher=Department of Justice|access-date=December 24, 2019|archive-url=https://web.archive.org/web/20110416090043/http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-32.html#h-28|archive-date=April 16, 2011}}</ref> It is illegal to possess without a prescription pursuant to Part G (section G.01.002) of the Food and Drug Regulations under the Food and Drugs Act.

*'''China:''' Methylphenidate is a controlled Class I psychotropic substances.<ref>《麻醉药品和精神药品品种目录（2023版）》-国有资产管理处 (tjnu.edu.cn)</ref> Prescriptions for psychotropic substances in Class I are generally limited to a 1-day supply, but those for controlled release formulation like Methylphenidate are limited to a 7-day supply.<ref>卫生部关于印发《麻醉药品、精神药品处方管理规定》的通知　　麻醉药品、精神药品处方管理规定__2006年第28号国务院公报_中国政府网 (www.gov.cn)</ref> This kind of substance is strictly limited.

*'''Germany''': Methylphenidate is a controlled substance under Anlage III of the BtMG. It can only be prescribed on a narcotic prescription form.<ref>{{Citation | title=Anlage III BtMG - Einzelnorm | url=http://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html}}</ref>

*'''New Zealand''': Methylphenidate is a 'Class B2 controlled substance'. Unlawful possession is punishable by six-month prison sentence and the distribution of it is punishable by a 14-year sentence.{{citation needed}}

@@ Line 67: / Line 67: @@
 *'''[[Effect::Ego inflation]]'''
 *'''[[Effect::Emotion suppression]]''' - This is typically most intense at light and common doses, and is more commonly reported from medical usage rather than recreational.
-*'''[[Effect::Derealisation]]''' - This effect is usually reaported at moderate/high doses.
+*'''[[Effect::Derealisation]]''' - This effect is usually reported at moderate/high doses.
 *'''[[Effect::Focus enhancement]]''' - This component is most effective at low to moderate dosages as anything higher will usually impair concentration.
 *'''[[Effect::Wakefulness]]'''
@@ Line 92: / Line 92: @@
 *'''[[Effect::Thought deceleration]]'''
 *'''[[Effect::Wakefulness]]'''
-Some users report methylphenidate to have stronger after-effects than [[amphetamine]] and [[caffeine]].
+When methylphenidate compared to other stimulants such as [[Amphetamine]] and [[Caffeine]] it has worse after effects, which is like [[MDMA]].
 }}
@@ Line 141: / Line 141: @@
 {{DangerousInteractions/Intro}}
 {{DangerousInteractions/Stimulants|self=methylphenidate}}
+*'''[[MDMA]]''' - The neurotoxic effects of MDMA may be increased when combined with other stimulants.
 {{DangerousInteractions/MAOI|nt=dopamine}}
@@ Line 150: / Line 151: @@
 *'''Austria''': Methylphenidate is legal for medical use under the AMG (Arzneimittelgesetz Österreich) and illegal when sold or possessed without a prescription under the SMG (Suchtmittelgesetz Österreich).{{citation needed}}
 *'''Canada''': Methylphenidate is listed in Schedule III of the Controlled Drugs and Substances Act (along with LSD, psychedelic mushrooms, and mescaline).<ref>{{cite web|url=http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-32.html#h-28|title=SCHEDULE III|publisher=Department of Justice|access-date=December 24, 2019|archive-url=https://web.archive.org/web/20110416090043/http://laws-lois.justice.gc.ca/eng/acts/C-38.8/page-32.html#h-28|archive-date=April 16, 2011}}</ref> It is illegal to possess without a prescription pursuant to Part G (section G.01.002) of the Food and Drug Regulations under the Food and Drugs Act.
-*'''China:''' Methylphenidate is a controlled Class I psychotropic substances.<ref>《麻醉药品和精神药品品种目录（2023版）》-国有资产管理处 (tjnu.edu.cn)</ref> Prescriptions for psychotropic substances in Class I are generally limited to a 1-day supply, but those for controlled release formulation like Methylphenidate are limited to a 7-day supply.<ref>卫生部关于印发《麻醉药品、精神药品处方管理规定》的通知　　麻醉药品、精神药品处方管理规定__2006年第28号国务院公报_中国政府网 (www.gov.cn)</ref> This kind of substance is strictly limited.
 *'''Germany''': Methylphenidate is a controlled substance under Anlage III of the BtMG. It can only be prescribed on a narcotic prescription form.<ref>{{Citation | title=Anlage III BtMG - Einzelnorm | url=http://www.gesetze-im-internet.de/btmg_1981/anlage_iii.html}}</ref>
 *'''New Zealand''': Methylphenidate is a 'Class B2 controlled substance'. Unlawful possession is punishable by six-month prison sentence and the distribution of it is punishable by a 14-year sentence.{{citation needed}}